HR. 2343In Committee
John W. Walsh Alpha-1 Home Infusion Act of 2025
Extends Medicare coverage to at home augmentation therapy for severe hereditary alpha-1 antitrypsin deficiency causing emphysema when furnished by qualified home infusion suppliers
Plain-English overview
What this bill does
Extends Medicare coverage to at home augmentation therapy for severe hereditary alpha-1 antitrypsin deficiency causing emphysema when furnished by qualified home infusion suppliers
Key points
- Require qualified home infusion suppliers
- Require clinician supervision
- Extend Medicare coverage
Current status
Where it stands
Status
In Committee
Latest action
2025-03-25 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Related context
Topics and policy areas
undefinedHealth